{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:27:40Z","timestamp":1757701660793,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0679-5","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:31:47Z","timestamp":1536712307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GNPTAB c.2404C\u2009&gt;\u2009T nonsense mutation in a patient with mucolipidosis III alpha\/beta: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Chi-Chun","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Li-Yan","family":"Tsung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam-Tim","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9811-9565","authenticated-orcid":false,"given":"Wing-Tat","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"679_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/500849","volume":"78","author":"M Kudo","year":"2006","unstructured":"Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha \/ beta -subunits precursor gene. Am J Hum Genet. 2006;78:451\u201363.","journal-title":"Am J Hum Genet"},{"key":"679_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1620\/tjem.150.63","volume":"150","author":"I Kurobane","year":"1986","unstructured":"Kurobane I, Inoue S, Gotoh Y, Kato S, Tamura M, Narisawa K, et al. Biochemical improvement after treatment by bone marrow transplantation in I-cell disease. Tohoku J Exp Med. 1986;150:63\u20138.","journal-title":"Tohoku J Exp Med"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bbmt.2014.06.019","volume":"20","author":"TC Lund","year":"2014","unstructured":"Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, et al. Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biol Blood Marrow Transplant. 2014;20:1847\u201351.","journal-title":"Biol Blood Marrow Transplant"},{"key":"679_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0006-291X(81)91177-3","volume":"98","author":"A Hasilik","year":"1981","unstructured":"Hasilik A, Waheed A, von Figura K. Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts. Biochem Biophys Res Commun. 1981;98:761\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"679_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1074\/jbc.M112.407676","volume":"288","author":"M Franke","year":"2013","unstructured":"Franke M, Braulke T, Storch S. Transport of the GlcNAc-1-phosphotransferase \u03b1\/\u03b2-subunit precursor protein to the Golgi apparatus requires a combinatorial sorting motif. J Biol Chem. 2013;288:1238\u201349.","journal-title":"J Biol Chem"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nm1305","volume":"11","author":"S Tiede","year":"2005","unstructured":"Tiede S, Storch S, L\u00fcbke T, Henrissat B, Bargal R, Raas-Rothschild A, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha\/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11:1109\u201312.","journal-title":"Nat Med"},{"key":"679_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jmg.2009.067736","volume":"47","author":"SS Cathey","year":"2010","unstructured":"Cathey SS, Leroy JG, Wood T, Eaves K, Simensen RJ, Kudo M, et al. Phenotype and genotype in mucolipidoses II and III alpha\/beta: a study of 61 probands. J Med Genet. 2010;47:38\u201348.","journal-title":"J Med Genet"},{"key":"679_CR8","doi-asserted-by":"crossref","unstructured":"Kollmann K, Damme M, Markmann S, Morelle W, Schweizer M, Hermans-Borgmeyer I, et al. Lysosomal dysfunction causes neurodegeneration in mucolipidosis II \u201cknock-in\u201d mice. Brain J Neurol. 2012;135 Pt 9:2661\u20132675.","DOI":"10.1093\/brain\/aws209"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1167\/iovs.07-0452","volume":"48","author":"CM Gelfman","year":"2007","unstructured":"Gelfman CM, Vogel P, Issa TM, Turner CA, Lee W-S, Kornfeld S, et al. Mice lacking alpha\/beta subunits of GlcNAc-1-phosphotransferase exhibit growth retardation, retinal degeneration, and secretory cell lesions. Invest Ophthalmol Vis Sci. 2007;48:5221\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/ajmg.a.33134","volume":"149A","author":"M Zarghooni","year":"2009","unstructured":"Zarghooni M, Dittakavi SSR. Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III. Am J Med Genet A. 2009;149A:2753\u201361.","journal-title":"Am J Med Genet A"},{"key":"679_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ppul.21599","volume":"47","author":"M Ishak","year":"2012","unstructured":"Ishak M, Zambrano EV, Bazzy-Asaad A, Esquibies AE. Unusual pulmonary findings in mucolipidosis II. Pediatr Pulmonol. 2012;47:719\u201321.","journal-title":"Pediatr Pulmonol"},{"key":"679_CR12","doi-asserted-by":"publisher","unstructured":"Wang Y, Ye J, Qiu W-J, Han L-S, Gao X-L, Liang L-L, et al. Identification of predominant GNPTAB gene mutations in eastern Chinese patients with mucolipidosis II\/III and a prenatal diagnosis of mucolipidosis II. Acta Pharmacol Sin. 2018; \n                    https:\/\/doi.org\/10.1038\/s41401-018-0023-9\n                    \n                  . [Epub ahead of print]","DOI":"10.1038\/s41401-018-0023-9"},{"key":"679_CR13","doi-asserted-by":"crossref","unstructured":"Blau N, Duran M, Gibson KM, Others. Laboratory guide to the methods in biochemical genetics. Springer: Springer-Verlag Berlin Heidelberg; 2008.","DOI":"10.1007\/978-3-540-76698-8"},{"key":"679_CR14","doi-asserted-by":"crossref","unstructured":"Ho C-C, Tai S-M, Lee EC-N, Mak TS-H, Liu TK-T, Tang VW-L, et al. Rapid identification of pathogenic variants in two cases of Charcot-Marie-tooth disease by gene-panel sequencing. Int J Mol Sci. 2017;18(4). Relevant PMID: 28379183","DOI":"10.3390\/ijms18040770"},{"key":"679_CR15","doi-asserted-by":"crossref","unstructured":"Fong W-Y, Ho C-C, Poon W-T. Comparison of direct sequencing, real-time PCR-high resolution melt (PCR-HRM) and PCR-restriction fragment length polymorphism (PCR-RFLP) analysis for genotyping of common Thiopurine intolerant variant alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C). Diagn Basel Switz. 2017;7(2). Relevant PMID: 28498350","DOI":"10.3390\/diagnostics7020027"},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/humu.20205","volume":"26","author":"KH Paik","year":"2005","unstructured":"Paik KH, Song SM, Ki CS, Yu H-W, Kim JS, Min KH, et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha\/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum Mutat. 2005;26:308\u201314.","journal-title":"Hum Mutat"},{"key":"679_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"679_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"key":"679_CR20","doi-asserted-by":"publisher","first-page":"e0163204","DOI":"10.1371\/journal.pone.0163204","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, Zhang W, Shi H, Yao F, Wei M, Qiu Z. Mutation analysis of 16 Mucolipidosis II and III alpha\/Beta Chinese children revealed genotype-phenotype correlations. PLoS One. 2016;11:e0163204.","journal-title":"PLoS One"},{"key":"679_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/B978-0-444-59565-2.00042-3","volume":"113","author":"JE Wraith","year":"2013","unstructured":"Wraith JE. Mucopolysaccharidoses and mucolipidoses. Handb Clin Neurol. 2013;113:1723\u20139.","journal-title":"Handb Clin Neurol"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5144\/0256-4947.2013.382","volume":"33","author":"M Alfadhel","year":"2013","unstructured":"Alfadhel M, AlShehhi W, Alshaalan H, Al Balwi M, Eyaid W, Eyaida W. Mucolipidosis II: first report from Saudi Arabia. Ann Saudi Med. 2013;33:382\u20136.","journal-title":"Ann Saudi Med"},{"key":"679_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00381-002-0627-7","volume":"18","author":"FM Aynaci","year":"2002","unstructured":"Aynaci FM, Cakir E, Aynaci O. A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis. Childs Nerv Syst. 2002;18:707\u201311.","journal-title":"Childs Nerv Syst"},{"key":"679_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","volume":"121","author":"SA Khan","year":"2017","unstructured":"Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121:227\u201340.","journal-title":"Mol Genet Metab"},{"key":"679_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-7-22","volume":"7","author":"MH de Ru","year":"2012","unstructured":"de Ru MH, Teunissen QG, van der Lee JH, Beck M, Bodamer OA, Clarke LA, et al. Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure. Orphanet J Rare Dis. 2012;7:22.","journal-title":"Orphanet J Rare Dis"},{"key":"679_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","volume":"41","author":"AB Burlina","year":"2018","unstructured":"Burlina AB, Polo G, Salviati L, Duro G, Zizzo C, Dardis A, et al. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in north East Italy. J Inherit Metab Dis. 2018;41:209\u201319.","journal-title":"J Inherit Metab Dis"},{"key":"679_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s13312-012-0247-6","volume":"49","author":"J Sheth","year":"2012","unstructured":"Sheth J, Mistri M, Kamate M, Vaja S, Sheth FJ. Diagnostic strategy for mucolipidosis II\/III. Indian Pediatr. 2012;49:975\u20137.","journal-title":"Indian Pediatr"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ajmg.a.38023","volume":"173","author":"CR Ferreira","year":"2017","unstructured":"Ferreira CR, Devaney JM, Hofherr SE, Pollard LM, Cusmano-Ozog K. Hereditary fructose intolerance mimicking a biochemical phenotype of mucolipidosis: a review of the literature of secondary causes of lysosomal enzyme activity elevation in serum. Am J Med Genet A. 2017;173:501\u20139.","journal-title":"Am J Med Genet A"},{"key":"679_CR29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1373\/clinchem.2016.269167","volume":"63","author":"Y Liu","year":"2017","unstructured":"Liu Y, Yi F, Kumar AB, Kumar Chennamaneni N, Hong X, Scott CR, et al. Multiplex tandem mass spectrometry enzymatic activity assay for newborn screening of the Mucopolysaccharidoses and type 2 neuronal ceroid Lipofuscinosis. Clin Chem. 2017;63:1118\u201326.","journal-title":"Clin Chem"},{"key":"679_CR30","doi-asserted-by":"publisher","first-page":"e0138622","DOI":"10.1371\/journal.pone.0138622","volume":"10","author":"EJ Langereis","year":"2015","unstructured":"Langereis EJ, Wagemans T, Kulik W, Lefeber DJ, van Lenthe H, Oussoren E, et al. A multiplex assay for the diagnosis of Mucopolysaccharidoses and Mucolipidoses. PLoS One. 2015;10:e0138622.","journal-title":"PLoS One"},{"key":"679_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","volume":"120","author":"F Kubaski","year":"2017","unstructured":"Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, et al. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Mol Genet Metab. 2017;120:247\u201354.","journal-title":"Mol Genet Metab"},{"key":"679_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","volume":"190","author":"BK Burton","year":"2017","unstructured":"Burton BK, Charrow J, Hoganson GE, Waggoner D, Tinkle B, Braddock SR, et al. Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience. J Pediatr. 2017;190:130\u20135.","journal-title":"J Pediatr"},{"key":"679_CR33","doi-asserted-by":"crossref","unstructured":"Brunelli MJ, Atallah \u00c1N, da Silva EMK. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI. Cochrane Database Syst Rev 2016;3:CD009806.","DOI":"10.1002\/14651858.CD009806.pub2"},{"key":"679_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/TACG.S57672","volume":"8","author":"AO Fedele","year":"2015","unstructured":"Fedele AO. Sanfilippo syndrome: causes, consequences, and treatments. Appl Clin Genet. 2015;8:269\u201381.","journal-title":"Appl Clin Genet"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"e0184065","DOI":"10.1371\/journal.pone.0184065","volume":"12","author":"AD Dornelles","year":"2017","unstructured":"Dornelles AD, Artigal\u00e1s O, da Silva AA, Ardila DLV, Alegra T, Pereira TV, et al. Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: a systematic review and meta-analysis. PLoS One. 2017;12:e0184065.","journal-title":"PLoS One"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-017-0635-z","volume":"12","author":"J Muenzer","year":"2017","unstructured":"Muenzer J, Jones SA, Tylki-Szyma\u0144ska A, Harmatz P, Mendelsohn NJ, Guffon N, et al. Ten years of the hunter outcome survey (HOS): insights, achievements, and lessons learned from a global patient registry. Orphanet J Rare Dis. 2017;12:82.","journal-title":"Orphanet J Rare Dis."},{"key":"679_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","volume":"47","author":"VK Prasad","year":"2010","unstructured":"Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Semin Hematol. 2010;47:59\u201369.","journal-title":"Semin Hematol"},{"key":"679_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biocel.2017.09.006","volume":"92","author":"NF Ludwig","year":"2017","unstructured":"Ludwig NF, Velho RV, Sperb-Ludwig F, Acosta AX, Ribeiro EM, Kim CA, et al. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms. Int J Biochem Cell Biol. 2017;92:90\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"679_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ymgme.2016.02.001","volume":"117","author":"A-R Ko","year":"2016","unstructured":"Ko A-R, Jin D-K, Cho SY, Park SW, Przybylska M, Yew NS, et al. AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II. Mol Genet Metab. 2016;117:447\u201355.","journal-title":"Mol Genet Metab"},{"key":"679_CR40","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/ajmg.a.37563","volume":"170A","author":"T Shibazaki","year":"2016","unstructured":"Shibazaki T, Hirabayashi K, Saito S, Shigemura T, Nakazawa Y, Sakashita K, et al. Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha\/beta. Am J Med Genet A. 2016;170A:1278\u201382.","journal-title":"Am J Med Genet A"},{"key":"679_CR41","first-page":"191","volume":"25","author":"MH-C Lin","year":"2012","unstructured":"Lin MH-C, Pitukcheewanont P. Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab JPEM. 2012;25:191\u20135.","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"679_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.bmt.1704249","volume":"32","author":"S Grewal","year":"2003","unstructured":"Grewal S, Shapiro E, Braunlin E, Charnas L, Krivit W, Orchard P, et al. Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: a long-term follow-up report. Bone Marrow Transplant. 2003;32:957\u201360.","journal-title":"Bone Marrow Transplant"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0679-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:16:26Z","timestamp":1568229386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0679-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0679-5","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of laboratory genetic information was approved by the Hong Kong Hospital Authority\/Hong Kong East Cluster Institutional Review Board Ethics Committee (HKEC-2016-047; approval date: 23 August 2016). Written informed consent for genetic testing and participating in the study was obtained from the subject\u2019s parents, on behalf of the minor subject. There was no treatment intervention involved in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent to publish this case report, including clinical images, and personal\/ clinical details that could compromise anonymity, was obtained from the subject\u2019s parents on behalf of the minor subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DBS and urine testing at National Taiwan University Hospital was provided freely by Sanofi Genzyme, USA. Sanofi Genzyme had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results. Other than above, the authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"162"}}